Literature DB >> 36279006

[Testosterone treatment].

Jens Rosellen1, Thorsten Diemer2, Arne Hauptmann2, Florian Wagenlehner2.   

Abstract

Male hypogonadism is a congenital or acquired disorder that exerts a negative influence on various organ functions and can massively impair the quality of life through the relative or absolute deficiency of testosterone. A variety of preparations are available for substitution treatment, which differ in administration form and intake interval. For the execution of testosterone treatment various guidelines exist with clear and practical instructions on the indications, contraindications, treatment procedure and monitoring. Of particular importance are cardiovascular aspects and diseases of the prostate gland, which underlines the central position of the urologist in the treatment.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Guidelines; Hormone replacement therapy; Hypogonadism; Late-onset hypogonadism; Testosterone deficiency

Year:  2022        PMID: 36279006     DOI: 10.1007/s00120-022-01957-7

Source DB:  PubMed          Journal:  Urologie        ISSN: 2731-7064


  58 in total

1.  Toward excellence in testosterone testing: a consensus statement.

Authors:  William Rosner; Hubert Vesper
Journal:  J Clin Endocrinol Metab       Date:  2010-10       Impact factor: 5.958

2.  Identification of late-onset hypogonadism in middle-aged and elderly men.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Jennifer M Beynon; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Steven Boonen; Dirk Vanderschueren; Fernand Labrie; Ilpo T Huhtaniemi
Journal:  N Engl J Med       Date:  2010-06-16       Impact factor: 91.245

3.  Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men - a suggested update.

Authors:  Bruno Lunenfeld; George Mskhalaya; Svetlana Kalinchenko; Yulia Tishova
Journal:  Aging Male       Date:  2013-11-04       Impact factor: 5.892

Review 4.  Steroid receptor/coactivator binding inhibitors: An update.

Authors:  Kornelia J Skowron; Kenneth Booker; Changfeng Cheng; Simone Creed; Brian P David; Phillip R Lazzara; Amy Lian; Zamia Siddiqui; Thomas E Speltz; Terry W Moore
Journal:  Mol Cell Endocrinol       Date:  2019-06-01       Impact factor: 4.102

Review 5.  Subclinical male hypogonadism.

Authors:  Elisa Giannetta; Daniele Gianfrilli; Federica Barbagallo; Andrea M Isidori; Andrea Lenzi
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

Review 6.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

Review 7.  Paediatric and adult-onset male hypogonadism.

Authors:  Andrea Salonia; Giulia Rastrelli; Geoffrey Hackett; Stephanie B Seminara; Ilpo T Huhtaniemi; Rodolfo A Rey; Wayne J G Hellstrom; Mark R Palmert; Giovanni Corona; Gert R Dohle; Mohit Khera; Yee-Ming Chan; Mario Maggi
Journal:  Nat Rev Dis Primers       Date:  2019-05-30       Impact factor: 52.329

8.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe Casanueva; Gianni Forti; Aleksander Giwercman; Ilpo T Huhtaniemi; Krzysztof Kula; Margus Punab; Steven Boonen; Dirk Vanderschueren
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

Review 9.  Which patients with sexual dysfunction are suitable for testosterone replacement therapy?

Authors:  A Morelli; G Corona; S Filippi; S Ambrosini; G Forti; L Vignozzi; M Maggi
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

Review 10.  A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management.

Authors:  Mathis Grossmann; Alvin M Matsumoto
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.